Association between adoption of evidence-based treatment and survival for patients with ST-elevation myo- cardial infarction. JAMA. 2011;305:1677 84. 19. Krumholz HM, Merrill AR, Schone EM, et al. Patterns of hospi- tal performance in acute myocardial infarction and heart failure 30- day mortality and readmission. Circ Cardiovasc Qual Outcomes. 2009;2:407 13. 20. Bradley EH, Curry LA, Spatz ES, et al. Hospital strategies for reducing risk-standardized mortality rates in acute myocardial infarction. Ann In- tern Med. 2012;156:618 26. 21. Gharacholou SM, Alexander KP, Chen AY, et al. Implications and reasons for the lack of use of reperfusion therapy in patients with ST-segment el- evation myocardial infarction: findings from the CRUSADE initiative. Am Heart J. 2010;159:757 63. 22. Subherwal S, Bach RG, Chen AY, et al. Baseline risk of major bleed- ing in non-ST-segment-elevation myocardial infarction: the CRUSADE (Can Rapid risk stratification of Unstable angina patients Suppress AD- verse outcomes with Early implementation of the ACC/AHA Guidelines) Bleeding Score. Circulation. 2009;119:1873 82. O Gara et al 2013 ACCF/AHA STEMI Guideline e403 23. Glickman SW, Granger CB, Ou F-S, et al. Impact of a statewide ST-seg- ment-elevation myocardial infarction regionalization program on treat- ment times for women, minorities, and the elderly. Circ Cardiovasc Qual Outcomes. 2010;3:514 21. 24. Wynia MK, Ivey SL, Hasnain-Wynia R. Collection of data on patients race and ethnic group by physician practices. N Engl J Med. 2010;362:846 50. 25. Grundy SM, Garber A, Goldberg R, et al. Prevention Conference VI: Dia- betes and Cardiovascular Disease: Writing Group IV: lifestyle and medi- cal management of risk factors. Circulation. 2002;105:e153 8. 26. Eckel RH, Kahn R, Robertson RM, et al. Preventing cardiovascular dis- ease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. Circulation. 2006;113:2943 6. 27. 